MEDICAL GENOMICS LTD

Company Registration Number:
04098979 (England and Wales)

Unaudited micro entity accounts for the year ended 31 October 2024

Period of accounts

Start date: 01 November 2023

End date: 31 October 2024

MEDICAL GENOMICS LTD

Contents of the Financial Statements

for the Period Ended 31 October 2024

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Footnotes to the Balance Sheet - 8

MEDICAL GENOMICS LTD

Company Information

for the Period Ended 31 October 2024




Director: Andrei Semikhodskii
Registered office: 134
Somerset Road
Wimbledon
London
SW19 5HP
Company Registration Number: 04098979 (England and Wales)

MEDICAL GENOMICS LTD

Directors' Report Period Ended 31 October 2024

The directors present their report with the financial statements of the company for the period ended 31 October 2024

Principal Activities

Forensic DNA consultancy

Additional information

The business activities of the company were severely affected by the consequences of SARS-CoV2 pandemics and by the war in Ukraine

Directors

The directors shown below have held office during the whole of the period from 01 November 2023 to 31 October 2024
Andrei Semikhodskii

This report was approved by the board of directors on 15 July 2025
And Signed On Behalf Of The Board By:

Name: Andrei Semikhodskii
Status: Director

MEDICAL GENOMICS LTD

Profit and Loss Account

for the Period Ended 31 October 2024


2024
£

2023
£
Turnover 1,035 347
Cost of Materials ( 1,479 ) ( 1,783 )
Profit or (Loss) for Period ( 444 ) ( 1,436 )

MEDICAL GENOMICS LTD

Balance sheet

As at 31 October 2024


2024
£

2023
£
Current assets: 13,363 13,247
Creditors: amounts falling due within one year: ( 101,366 ) ( 100,356 )
Net current assets (liabilities): ( 88,003 ) ( 87,109 )
Total assets less current liabilities: ( 88,003 ) ( 87,109 )
Creditors: amounts falling due after more than one year: ( 194,136 ) ( 187,985 )
Total net assets (liabilities): ( 282,139 ) ( 275,094 )
Capital and reserves: ( 282,139 ) ( 275,094 )

MEDICAL GENOMICS LTD

Balance sheet continued

For the year ending 31 October 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 15 July 2025
And Signed On Behalf Of The Board By:

Name: Andrei Semikhodskii
Status: Director

The notes form part of these financial statements

MEDICAL GENOMICS LTD

Footnotes to the Financial Statements

for the Period Ended 31 October 2024

  • 1. Employee Information

    Average number of employees: 1

MEDICAL GENOMICS LTD

Footnotes to the Financial Statements

for the Period Ended 31 October 2024

  • 2. Off balance sheet disclosure

    No